InvestorsHub Logo
Followers 840
Posts 120476
Boards Moderated 18
Alias Born 09/05/2002

Re: pollyvonwog post# 890

Friday, 02/13/2015 11:24:37 AM

Friday, February 13, 2015 11:24:37 AM

Post# of 3205
It’s a competitive advantage for ABBV to not have V-Pak prescriptions publicly disclosed. In that way, ABBV sees the whole (US) market while GILD sees only part of it.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent ENTA News